Illustration depicting Abbott Laboratories as a futuristic healthcare city with FreeStyle Libre glucose sensors, cancer diagnostics trains labeled Cologuard and Cancerguard, happy doctors and patients, and a giant Dividend King castle.

🩺 Abbott Laboratories (ABT) Stock Analysis: Can a Dividend King Turn Exact Sciences Into Its Next Growth Engine?

Abbott Laboratories may not be flashy, but the healthcare giant combines insider buying, a growing oncology diagnostics platform, the dominant FreeStyle Libre franchise, and more than a century of dividend payments. With shares trading near 16x forward earnings, investors may be looking at a classic Growth at a Reasonable Price opportunity.

Read entire article

Cinematic illustration of Boston Scientific as a futuristic medtech powerhouse, with glowing cardiovascular devices, a heart-shaped stock chart, doctors, investors, and a $2B buyback shield symbolizing healthcare innovation and a GARP stock opportunity.

🫀 Boston Scientific (BSX): A GARP Reset on a Medical Device Powerhouse

Boston Scientific stock has fallen nearly 48% from its highs, but the business engine remains strong. With double-digit revenue growth, major cardiovascular catalysts, director insider buying, low short interest, and a $2B buyback, BSX may be one of the cleaner large-cap healthcare GARP setups on the market.

Read entire article